Soetomo COVID-19 Prognostic Score: A Multi-Parametric Model for Early Prediction of Disease Severity of COVID-19 in Tertiery -Resource Hospital

N. Kurniati, Ari Utariani, I. Syafa'ah, R. Setiawati, Anita Widyoningroem, Firly Hayati
{"title":"Soetomo COVID-19 Prognostic Score: A Multi-Parametric Model for Early Prediction of Disease Severity of COVID-19 in Tertiery -Resource Hospital","authors":"N. Kurniati, Ari Utariani, I. Syafa'ah, R. Setiawati, Anita Widyoningroem, Firly Hayati","doi":"10.31584/jhsmr.20241044","DOIUrl":null,"url":null,"abstract":"Objective: Coronavirus disease 2019 (COVID-19) became a global pandemic, with high mortality in severely ill patients. This study aimed to develop a novel scoring system to prognosticate disease severity in COVID-19 patients that is effective and widely available in tertiary medical resource settings.Material and Methods: Laboratory-confirmed COVID-19 patients were enrolled in this retrospective cohort, divided into severe and non-severe groups. We randomly assigned 70% of the subjects to establish a novel scoring system, while the remaining 30% was used for internal validation. The model was constructed by multivariate logistic regression using the first clinical, laboratory, and radiological finding of statistically analysis of group patients. receiver operating characteristic (ROC) and cross-tabulation were used to evaluate the performance of our score and compare it with other models.Results: A total of 599 patients were included. The Soetomo COVID-19 prognostic score predictors included age, fever, specific comorbidities (diabetes, hypertension, cardiac disease, lung tuberculosis), respiratory rate, heart rate, SF ratio, whole blood cell (WBC) count, neutrophil lympocyte ratio (NLR), blood urea nitrogen (BUN), and a RALE score. The area under the ROC of the model indicated an excellent discriminatory ability (training datasets 0.715 [95% CI 0.664-0.767, p-value<0.001]; testing datasets 0.720 [95% CI 0.638-0.802, p-value<0.001]). Our scoring system was superior to both qSOFA and MEWS regarding predictive value. The sensitivity and specificity were 60.6% and 82.5%, respectively.Conclusion: The developed scoring system accurately predicted a significant proportion of severe disease in COVID-19 patients.","PeriodicalId":36211,"journal":{"name":"Journal of Health Science and Medical Research","volume":"12 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Science and Medical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31584/jhsmr.20241044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Coronavirus disease 2019 (COVID-19) became a global pandemic, with high mortality in severely ill patients. This study aimed to develop a novel scoring system to prognosticate disease severity in COVID-19 patients that is effective and widely available in tertiary medical resource settings.Material and Methods: Laboratory-confirmed COVID-19 patients were enrolled in this retrospective cohort, divided into severe and non-severe groups. We randomly assigned 70% of the subjects to establish a novel scoring system, while the remaining 30% was used for internal validation. The model was constructed by multivariate logistic regression using the first clinical, laboratory, and radiological finding of statistically analysis of group patients. receiver operating characteristic (ROC) and cross-tabulation were used to evaluate the performance of our score and compare it with other models.Results: A total of 599 patients were included. The Soetomo COVID-19 prognostic score predictors included age, fever, specific comorbidities (diabetes, hypertension, cardiac disease, lung tuberculosis), respiratory rate, heart rate, SF ratio, whole blood cell (WBC) count, neutrophil lympocyte ratio (NLR), blood urea nitrogen (BUN), and a RALE score. The area under the ROC of the model indicated an excellent discriminatory ability (training datasets 0.715 [95% CI 0.664-0.767, p-value<0.001]; testing datasets 0.720 [95% CI 0.638-0.802, p-value<0.001]). Our scoring system was superior to both qSOFA and MEWS regarding predictive value. The sensitivity and specificity were 60.6% and 82.5%, respectively.Conclusion: The developed scoring system accurately predicted a significant proportion of severe disease in COVID-19 patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Soetomo COVID-19 预后评分:用于早期预测三级资源医院 COVID-19 疾病严重程度的多参数模型
目的:冠状病毒病 2019(COVID-19)已成为一种全球性流行病,重症患者的死亡率很高。本研究旨在开发一种新型评分系统,用于预测COVID-19患者的疾病严重程度,该系统在三级医疗资源环境中有效且可广泛使用:这项回顾性队列研究招募了经实验室确诊的COVID-19患者,将其分为严重组和非严重组。我们随机分配了 70% 的受试者建立新的评分系统,其余 30% 的受试者用于内部验证。采用多变量逻辑回归法构建模型,使用统计分析组患者的首个临床、实验室和放射学发现。接受者操作特征(ROC)和交叉表法用于评估我们的评分性能,并将其与其他模型进行比较:结果:共纳入 599 例患者。Soetomo COVID-19 预后评分预测指标包括年龄、发热、特定合并症(糖尿病、高血压、心脏病、肺结核)、呼吸频率、心率、SF 比值、全血细胞(WBC)计数、中性粒细胞淋巴细胞比值(NLR)、血尿素氮(BUN)和 RALE 评分。该模型的 ROC 下面积显示了出色的判别能力(训练数据集为 0.715 [95% CI 0.664-0.767,p 值<0.001];测试数据集为 0.720 [95% CI 0.638-0.802,p 值<0.001])。在预测价值方面,我们的评分系统优于 qSOFA 和 MEWS。灵敏度和特异度分别为 60.6% 和 82.5%:结论:所开发的评分系统能准确预测 COVID-19 患者中相当一部分重症患者的病情。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
0
审稿时长
14 weeks
期刊最新文献
Hospital Food Waste Trends: A Bibliometric Analysis Effectiveness of a Patient-Family-Shared Care Program on Delaying the Progression of Chronic Kidney Disease in Uncontrolled Type 2 Diabetic Patients: A Quasi-Experimental Study Association between Retinal Morphology and Visual Functions in Eyes with Typical Neovascular Age Related Macular Degeneration: A Pilot Study Association of Online Learning Tools and Students’ Health: A Case Study During the COVID-19 Pandemic Comparative Efficacy of Oxitard Capsules and Immusante Tablets in Early Stages of Oral Submucous Fibrosis - A Randomized Controlled Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1